Related references
Note: Only part of the references are listed.PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential
Bharath K. Velmurugan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer
Tatiana V. Macfarlane et al.
CANCER EPIDEMIOLOGY (2015)
Expression of COX-2 and HER-2 in colorectal cancer and their correlation
Qi-Bing Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Positive nuclear expression of KLF8 might be correlated with shorter survival in gastric adenocarcinoma
Li-Sung Hsu et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2014)
Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation
Ion Cristobal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo
Hong Zhang et al.
ONCOLOGY REPORTS (2014)
Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo
Ming Qian et al.
ONCOLOGY REPORTS (2014)
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
Katja Hattar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Parthasarathy Seshacharyulu et al.
CANCER LETTERS (2013)
Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling
Zi-li Wang et al.
CARCINOGENESIS (2013)
An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers et al.
CLINICAL CANCER RESEARCH (2013)
Protein phosphatase 2A: a target for anticancer therapy
Danilo Perrotti et al.
LANCET ONCOLOGY (2013)
Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells
Ye-Won Jeon et al.
ONCOLOGY REPORTS (2013)
PP2A-Mediated Anticancer Therapy
Weibo Chen et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth
Xiao-Pu He et al.
FEBS JOURNAL (2012)
Desmoplastic Small Round Cell Tumor-Clinicopathological Spectrum, Including Unusual Features and Immunohistochemical Analysis of 45 Tumors Diagnosed at a Tertiary Cancer Referral Centre, with Molecular Results t(11;22) (p13; q12) (EWS-WT1) in Select Cases
Bharat Rekhi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis
Patrick M. Lynch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Prognostic Value of the Sixth Edition of the UICC's TNM Classification and Stage Grouping for Oral Cancer
Matthias Kreppel et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Protein phosphatase 2A regulatory subunits and cancer
Pieter J. A. Eichhorn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
Angeliki Voulgari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells
Jun Qin et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation
Yuji Kurihara et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Selective inhibition of cycloxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo
Xuan-Fu Xu et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Jukka Westermarck et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: Inhibition of tumor angiogenesis with extensive tumor necrosis
Khong Bee Kang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach
CZ Xing et al.
SURGERY TODAY (2005)
Vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells
W Cui et al.
CLINICAL CANCER RESEARCH (2005)
Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells
M Fujita et al.
ORAL ONCOLOGY (2004)
Okadaic acid, useful tool for studying cellular processes
JJ Fernandez et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Share Paper
